We’re proud to announce our recent acceptance as a member organization within the Canadian Cancer Research Alliance (CCRA).

Both organizations are aligned in our objective and promise of fostering collaboration among organizations dedicated to advancing cancer research and improving the lives of those affected by cancer, making this relationship extremely promising. 

Myeloma Canada is fully committed to advancing cancer research, improving patient outcomes, and enhancing the cancer landscape in Canada. By joining the CCRA, we can better amplify the voices of our community and advocate for national research funding that addresses the unique needs and challenges faced by cancer patients. Membership also provides us with invaluable opportunities for exchanging and sharing knowledge, insights, best practices, networking, and collaboration with fellow member organizations in our collective effort to combat cancer. 

Together we’re stronger! 

——-

The CCRA is an alliance of organizations that work strategically to co-ordinate and collaborate on most of the cancer research conducted in Canada. Together we support cancer research that uncovers factors which may cause cancer, and discovers more—and better—treatments to improve patient and survivor outcomes.